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Summary
 
The role of the classical complement pathway in humoral immune responses was investigated
in gene-targeted C1q-deficient mice (
 
C1qA
 
2
 
/
 
2
 
). Production of antigen-specific immunoglob-
ulin (Ig)G2a and IgG3 in primary and secondary responses to T cell–dependent antigen was
significantly reduced, whereas IgM, IgG1, and IgG2b responses were similar in control and
 
C1qA
 
2
 
/
 
2
 
 mice. Despite abnormal humoral responses, B cells from 
 
C1qA
 
2
 
/
 
2
 
 mice proliferated
normally to a number of stimuli in vitro. Immune complex localization to follicular dendritic
cells within splenic follicles was lacking in 
 
C1qA
 
2
 
/
 
2
 
 mice. The precursor frequency of antigen-
specific T cells was similar in 
 
C1qA
 
2
 
/
 
2
 
 and wild-type mice. However, analysis of cytokine
production by primed T cells in response to keyhole limpet hemocyanin revealed a significant
reduction in interferon-
 
g
 
 production in 
 
C1qA
 
2
 
/
 
2
 
 mice compared with control mice, whereas
interleukin 4 secretion was equivalent. These data suggest that the classical pathway of comple-
ment may influence the cytokine profile of antigen-specific T lymphocytes and the subsequent
immune response.
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A
 
large body of evidence supports a role for the comple-
ment system in the induction of the humoral arm of
the immune response. Mice transiently depleted of com-
plement by cobra venom factor administration before im-
munization with T cell–dependent (TD)
 
1
 
 antigen had
markedly reduced IgG antibody production (1, 2) and defi-
cient development of B cell memory (3). Observations made
in animals with congenital deficiencies in individual comple-
ment components confirmed the findings from transiently
decomplemented mice. Guinea pigs (4), dogs (5), and hu-
mans (6, 7) deficient in complement components C2, C3,
or C4 exhibited significantly reduced primary and second-
ary total IgG production in response to TD antigens. Re-
cently, engineered C3 and C4 knockout mice showed a
similar phenotype (8). In contrast, C5-deficient mice de-
veloped normal antibody responses (9). However, the re-
quirement for complement in the induction of antibody
responses was found not to be absolute. Reduced antibody
responses could be overcome in C3-deficient animals (10)
and C4-deficient guinea pigs (11) by introducing antigen
with adjuvant or by priming with large doses of antigen.
Two nonmutually exclusive models have been proposed
to explain the influence of complement on the induction
of humoral immune responses. The first suggests that com-
plement is crucial for the correct delivery, presentation, and
retention of antigen in lymphoid organs. Murine CD21
expression is primarily limited to B cells and follicular den-
dritic cells (FDCs) (12). FDCs retain unprocessed antigen
in the form of immune complexes (13) and are thought to
be involved in the generation of antibody responses within
the germinal center and the maintenance of immunological
memory (14, 15). Immune complex localization to germi-
nal centers (16) and splenic lymphoid follicles (3) was abol-
ished in mice decomplemented with cobra venom factor
and in rats treated with anti-C3 mAb (17). Furthermore,
enhanced uptake and presentation of antigen by B cells via
CD21 was observed in vitro with Ag coupled to C3dg
(18).
The second model suggests that complement, in combi-
nation with antigen, lowers the threshold required for B
cell activation. This model follows from observations that
activation of B cells is enhanced through interaction of C3
 
1
 
Abbreviations used in this paper:
 
 FDC, follicular dendritic cell; GCDC,
dendritic cell identified within murine germinal center; HAGG, heat-
aggregated human 
 
g
 
-globulin; IDC, interdigitating dendritic cell; PNA,
peanut agglutinin; TD, T cell–dependent.
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with CD21 (19). CD21 can be associated with CD19, a B
cell membrane protein essential for the regulation of B cell
responses, differentiation, and development (20). It has
been shown in vitro that B cells can bind C3 activation
products (21). Subsequent studies demonstrated that the
threshold for specific B cell activation in vitro was lowered
when antigen was coupled with C3d (19). Competitive in-
hibition or blockade of CD21–C3d interaction by soluble
CR2–Ig fusion protein (22), or mAb with specificity for
CR2 (23–25), abolished antibody production in vivo. Sim-
ilar data were obtained from 
 
Cr2
 
2
 
/
 
2
 
 mice, where reduced
humoral immune responses to TD antigens were observed
(26, 27). Strongest support for this model was provided by
chimeric mice with CR2 expression absent exclusively on
B cells. Antibody responses were comparable to those ob-
served in 
 
Cr2
 
2
 
/
 
2
 
 mice (28).
At present, little is known about the role of complement
in the regulation of antibody isotype production in re-
sponse to TD antigen. We report here studies on the role
of the classical pathway of complement on the induction of
antibody production and class switching in response to TD
antigen in C1q-deficient mice (29).
 
Materials and Methods
 
Mice. C1qA
 
2
 
/
 
2
 
 mice used were 129/Sv or on a (129/Sv 
 
3
 
C57BL/6) F
 
2
 
 mixed genetic background as specified in each ex-
periment, and were generated as previously described (29). Age-,
strain-, and sex-matched mice were used as controls. Animals
were maintained in specific pathogen-free conditions.
 
Immunization Protocols for Antibody Responses. C1qA
 
2
 
/
 
2
 
 and con-
trol wild-type mice were immunized intraperitoneally with (
 
a
 
) a
10% SRBC suspension in PBS and challenged with an equal dose
21 d after the initial immunization and (
 
b
 
) 6 
 
3
 
 10
 
6
 
 SRBCs cou-
pled with DNP-KLH (Calbiochem-Novabiochem Corp., La
Jolla, CA). SRBCs were coated with DNP-KLH using the chro-
mic chloride method (30) or (
 
c
 
) 10 
 
m
 
g DNP-KLH precipitated in
alum. Mice primed intraperitoneally with 6 
 
3
 
 10
 
6
 
 SRBCs cou-
pled with DNP-KLH were challenged intravenously on day 43
with 10 
 
m
 
g soluble DNP-KLH. Blood samples were taken before
immunization and at further time points specified for each exper-
iment.
 
Measurement of Anti-SRBC Antibodies.
 
Anti-SRBC total Ig or
IgG was measured by hemagglutination assay as previously de-
scribed (31). In brief, heat-inactivated serum from immunized
mice was serially diluted on v-bottomed microtiter plates and
mixed with a 2% SRBC suspension in the presence or absence of
2-mercaptoethanol. Plates were read “blind” by a different person
than the one who had set up the assay to assess agglutination titer
after a 4-h incubation at 4
 
8
 
C.
 
Measurement of DNP-specific Ig Isotypes.
 
ELISA plates (Dyna-
tech Labs Ltd., Billinghurst, UK) were coated with 50 
 
m
 
l DNP-BSA
(Calbiochem-Novabiochem Corp.) or goat anti–mouse Ig (H 
 
1
 
 L;
5 
 
m
 
g/ml; Southern Biotechnology Assoc., Birmingham, AL) diluted
in carbonate/bicarbonate buffer, pH 9.6, and incubated at 4
 
8
 
C
overnight. Plates were blocked with 1% BSA in PBS. Test sera
were diluted in PBS–Tween 0.05% and 50 
 
m
 
l of diluted sera was
incubated for 1 h at room temperature in duplicate. Each assay
included affinity-purified mouse IgM, IgG1, IgG2a, IgG2b, or
IgG3 (0.5 
 
m
 
g/ml; Sigma Chemical Co., Poole, UK), which were
titrated to generate standard curves. Plates were washed and fur-
ther incubated with alkaline phosphatase–conjugated goat anti–
mouse isotype-specific antibodies (0.2 
 
m
 
g/ml in PBS-Tween 0.05%;
Southern Biotechnology Assoc.) for 1 h at room temperature.
The plates were developed using the substrate 
 
p
 
-nitrophenyl
phosphate (Sigma Chemical Co.). The OD of the reaction mix-
ture at 405-nm wavelength was measured using an ELISA reader
(Titertek Labsystems, Basingstoke, UK). The relative concentra-
tion of specific Ig isotypes in individual samples was calculated by
comparing the mean OD obtained for duplicate wells minus non-
specific binding to the titrated mouse Ig isotype standard curve.
 
Limiting Dilution Analysis.
 
Wild-type and 
 
C1qA
 
2
 
/
 
2
 
 mice were
immunized intraperitoneally with 10 
 
m
 
g DNP-KLH in alum.
The frequency of antigen-specific T cells in the spleen was deter-
mined by IL-2 limiting dilution analysis 15–16 d after priming, as
previously described (32). In brief, splenocytes taken from unim-
munized mice were depleted of T cells and irradiated (25 Gy).
4 
 
3
 
 10
 
4
 
 of these antigen-presenting cells were added to limiting
numbers of splenocytes, with and without 50 
 
m
 
g/ml KLH in 96-
well plates. 24 identical wells were set up at each concentration of
responder cells. 2 d later, plates were irradiated (25 Gy), and 10
 
4
 
cells of the IL-2–dependent cell line, CTLL, were added to each
well. After 8 h of culture, proliferation was measured by uptake
of [
 
3
 
H]thymidine over 16 h. Positive wells exhibited a prolifera-
tion of greater than the mean plus three SD of control wells with
no responder cells. The frequency of antigen-specific cells was
calculated by regression analysis of the number of positive wells at
each dilution of responder cells.
 
Measurement of Cytokines. C1qA
 
2
 
/
 
2
 
 mice and controls were
immunized intraperitoneally with 10 
 
m
 
g DNP-KLH in alum.
Spleens were removed at day 14 after priming and a splenic
mononuclear cell suspension was generated after lysis of red blood
cells with Gey’s medium. Cells were plated at 5 
 
3
 
 10
 
5
 
 cells/well
in 200 
 
m
 
l medium in round-bottomed 96-well plates. The splenic
cell suspension was pulsed with 10 
 
m
 
g/ml soluble KLH and su-
pernatants were taken on days 4 and 7 of culture. Supernatants
were tested for IFN-
 
g
 
 activity by a sandwich ELISA as previously
described (33). In brief, antibodies to mouse IFN-
 
g
 
 were used for
coating of ELISA plates, followed by addition of supernatants to
be tested for the presence of IFN-
 
g
 
, capture by a second biotiny-
lated IFN-
 
g
 
–specific antibody, and detection with streptavidin
conjugated with alkaline phosphatase. Supernatants were also
tested for IL-4 activity using the IL-4–dependent cell line CT.4S
(34). Proliferation was assessed by the uptake of [
 
3
 
H]thymidine
(1 
 
m
 
Ci/well).
 
B Cell Proliferation.
 
A splenic mononuclear cell suspension
was generated after lysis of red blood cells with Gey’s medium. B
cells were purified by incubating the cell suspension with mAbs
specific for CD4, CD8, and Thy-1. Stained cells were subse-
quently lysed with rabbit complement. Purified splenic B cells
from two 
 
C1qA
 
2
 
/
 
2
 
 or wild type controls were plated in triplicate
at 2 
 
3
 
 10
 
5
 
/ml in 96-well plates in IMDM (GIBCO, Paisley, UK)
supplemented with 5% heat-inactivated FCS, 5 
 
3
 
 10
 
2
 
5
 
 M 2-mer-
captoethanol, 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin
(Sigma Chemical Co.). B cells were stimulated with 1 
 
m
 
g LPS
(
 
Salmonella typhosa
 
 0901; Difco, Detroit, MI), anti-CD40, FGK
45 (35), or 10 
 
m
 
g monoclonal anti–mouse 
 
k
 
 chain (187.1; Amer-
ican Type Culture Collection, Rockville, MD) plus IL-4 (36). B
cell proliferation was assessed at 48 h by the uptake of [
 
3
 
H]thy-
midine.
 
Localization of Immune Complexes.
 
Human 
 
g
 
-globulins, Cohn’s
fractions II and III (Sigma Chemical Co.), were heat aggregated ac-
cording to Brown et al. (37). The heat-aggregated human 
 
g
 
-globu- 
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lins (HAGG) were labeled with the fluorochrome FITC. 
 
C1qA
 
2
 
/
 
2
 
and control mice were injected intravenously with 500 
 
m
 
g FITC-
HAGG. Spleens were removed at 24 h and frozen in Tissue-Tek
OCT compound (Miles Inc., Elkhart, IN) and stored at 
 
2
 
70
 
8
 
C.
6-
 
m
 
m sections cut on a cryostat microtome were thaw mounted
onto Vectabond-treated slides (Vector Labs., Peterborough, UK),
fixed in acetone for 5 min at room temperature, and stored at
 
2
 
70
 
8
 
C. Splenic sections were rehydrated in PBS before staining
with peanut agglutinin (PNA)-biotin (Vector Labs.) and mAb
FDC-M1-biotin. PNA and FDC-M1 staining was revealed by
streptavidin–Texas red (Southern Biotechnology Assoc.) and sec-
tions were mounted using Vectashield (Vector Labs.).
 
Statistics.
 
Data are shown as mean values 
 
6
 
 SEM or SD
where specified. The Mann-Whitney U nonparametric test was
used to analyze the difference between 
 
C1qA
 
2
 
/
 
2
 
 and wild-type
immune responses. Differences were considered significant when
P ,0.05.
Results
Antibody Responses to T Cell–dependent Antigen in C1q-
deficient Mice. Primary and secondary total Ig and IgG ti-
ters were analyzed in C1q-deficient and wild-type mice
immunized with SRBCs. Anti-SRBC total Ig titers, mea-
sured in hemagglutination assay, were similar in C1qA2/2
and wild-type mice in the primary response. In contrast,
peak anti-SRBC Ig titers were significantly reduced in
C1qA2/2 (939 6 85 SEM) compared with wild-type mice
(2,731 6 629) (P ,0.02) in the secondary response (Fig. 1
A). In addition, anti-SRBC IgG titers were significantly re-
duced in C1qA2/2 (53.3 6 7) versus wild-type (154 6 26)
mice (P ,0.02) in the primary response at day 8 after im-
munization. Similar findings were obtained in the second-
ary anti-SRBC IgG response (C1qA2/2 mice: 277.7 6
51.35 versus controls: 768 6 114.4) (P ,0.02) (Fig. 1 B).
Antibody responses to TD antigen were then investi-
gated in greater detail in C1qA2/2 mice. Wild-type (129/
Sv 3 C57BL/6) F2 and C1qA2/2 mice were immunized
with SRBCs coated with DNP-KLH. This model permit-
ted the analysis of isotype-specific antibody responses to
soluble hapten-protein TD antigen in the absence of adju-
vant. The primary antibody response to DNP revealed a
novel and unexpected pattern of isotype-specific antibody
class switching. Anti-DNP–specific IgM, IgG1, and IgG2b
isotype production was similar in C1qA2/2 and control
mice (Fig. 2). However, mean anti-DNP IgG2a antibody
production on day 10 after priming was significantly re-
duced in C1q-deficient mice compared to wild-type ani-
mals (2.8 mg/ml 6 0.8 versus 8.3 mg/ml 6 2, respectively)
(P ,0.02) (Fig. 2). Furthermore, anti-DNP IgG3 antibody
production in C1qA2/2 mice (0.5 mg/ml 6 0.25) was re-
duced (P ,0.05) when compared to the response of wild-
Figure 1. Anti-SRBC Ig and IgG responses in C1qA2/2 mice. Wild-
type (129/Sv 3 C57BL/6) (j; n 5 6) and strain-matched C1qA2/2 (s;
n 5 6) mice were immunized intraperitoneally with a 10% SRBC sus-
pension and boosted on day 21 with a similar dose. Blood samples were
first taken on days 0, 4, 6, and 8 and subsequently on days 21, 23, 25, 27,
and 29 after immunization. Anti-SRBC total Ig (A) and IgG (B) antibody
responses were determined by hemagglutination assay as detailed in the
experimental procedures section. All results are represented as means 6
SEM. Significance was determined by the Mann-Whitney U test. * P
,0.05, ** P ,0.02, *** P ,0.002.
Figure 2. TD antigen isotype-
specific antibody responses in
C1qA2/2 mice. Wild-type (129/
Sv 3 C57BL/6) (j; n 5 5) and
strain-matched C1qA2/2 (s; n 5
5) mice were immunized intra-
peritoneally with a suspension of
6  3 106 SRBCs coated with
DNP-KLH. Mice were bled on
days 4, 10, 14, and 21 after immu-
nization. Anti-DNP isotype-spe-
cific responses were measured by
ELISA. All results are represented
as means 6 SEM. Significance was
determined by the Mann-Whitney
U test. * P ,0.05, ** P ,0.02.1792 Defective Immune Responses in C1q Knockout Mice
type controls (1.7 mg/ml 6 0.7) on day 21 after priming
(Fig. 2). A similar pattern of isotype production was ob-
served in response to SRBCs in the same mice (data not
shown).
Anti-DNP isotype-specific responses were also measured
in  C1qA2/2 and control mice on a pure genetic back-
ground (129/Sv). Control and gene-targeted mice were
immunized with 10 mg DNP-KLH precipitated in alum.
Again, significantly reduced anti-DNP IgG2a and IgG3
production was observed in C1qA2/2 mice compared with
controls. IgM, IgG1, and IgG2b anti-DNP production was
similar in wild-type and knockout mice (Table 1).
Mice primed with SRBC–DNP-KLH were challenged
with 10 mg soluble DNP-KLH at day 43 after immuniza-
tion and isotype-specific anti-DNP antibody responses
were analyzed. The secondary anti-DNP IgM response was
similar in C1qA2/2 and wild-type mice, as was a poor
IgG2b antigen-specific response (Fig. 3). Anti-DNP IgG1
production was marginally reduced in C1qA2/2 mice in
the secondary response compared to the response in con-
trol mice (34 mg/ml 6 10.4 versus 62.9 mg/ml 6 10.3, re-
spectively) on day 10 after challenge, though this result was
not statistically significant (Fig. 3). However, anti-DNP
IgG2a production was again significantly reduced in C1qA2/2
mice (3 mg/ml 6 1.525) compared to wild-type controls
(52.1 mg/ml 6 17) (P ,0.05) at day 14 after challenge.
The secondary DNP-specific IgG3 response was also sig-
nificantly diminished in C1qA2/2 mice (1 mg/ml 6 0.4) in
contrast to the mean control response (3 mg/ml 6 0.5) (P
,0.05) at 10 d after challenge (Fig. 3).
Cytokine Production and Precursor Frequency of Antigen-spe-
cific T Cells in C1qA2/2 Mice. Gene-targeted and control
mice were immunized intraperitoneally with 10 mg DNP-
KLH in alum. The frequency of antigen-specific splenic T
cells was assessed 15–16 d after priming in limiting dilution
analysis. The mean frequency of antigen-specific T cells
primed after immunization with KLH was similar in wild
type: 1/17,316 (n 5 4) and C1qA2/2: 1/15,983 (n 5 4)
mice (Fig. 4). Antigen-specific cytokine production by
primed T cells was studied further. Mice were immunized
intraperitoneally with 10 mg DNP-KLH in alum. Whole
splenic cell suspensions were pulsed with 10 mg/ml KLH
and cytokine secretion was assessed on days 4 and 7 of cul-
ture. IFN-g production (Fig. 5 A) was significantly dimin-
ished in splenic cells from C1qA2/2 mice when compared
to controls (P ,0.01). In contrast, IL-4 (Fig. 5 B) produc-
tion, when detectable after 7 d of culture, was equivalent in
the two experimental groups. Similar results were obtained
in two further experiments (data not shown).
Proliferation of B Cells from C1qA2/2 Mice. Considering
the aberrant B cell responses in C1qA2/2 mice after immu-
nization with TD antigen, we asked whether these obser-
vations were a result of a defect within the B cell popula-
tion resulting from the absence of functional C1q. B cells
purified from wild-type and C1q-deficient mice were in-
cubated with a number of B cell mitogens. B lymphocytes
Table 1. Reduced TD Antigen-specific IgG2a and IgG3 Isotype 
Production by C1qA2/2 Mice
Anti-DNP
Ig isotype 129/Sv C1qA2/2
IgM 30.6 6 17.9 16.99 6 6.5
IgG1 18.54 6 2.06 21.33 6 3.60
IgG2a 16.44 6 2.63 8.46 6 1.92**
IgG2b 5.34 6 1.61 4.67 6 1.29
IgG3 0.333 6 0.059 0.191 6 0.0465*
Pure line 129/Sv (n 5 6) and strain-matched C1qA2/2 (129/Sv) mice
(n 5 7) were immunized intraperitoneally with 10 mg DNP-KLH in
alum. Anti-DNP isotype production was measured on day 14 after
priming. The data represents antigen-specific isotype production in mi-
crograms per milliliter of serum as means 6 SEM. Significance was de-
termined by the Mann-Whitney U test. *P ,0.05, ** P ,0.02.
Figure 3. Secondary isotype-
specific antibody response to TD
antigen. Wild-type (129/Sv 3
C57BL/6;  j;  n  5 5) and strain-
matched  C1qA2/2 (s; n 5 5) mice
primed with 6 3 106 SRBCs
coated with DNP-KLH were chal-
lenged intravenously on day 43 af-
ter immunization with 10 mg solu-
ble DNP-KLH. Blood samples
were taken on days 42, 46, 50, 53,
and 57 after immunization. All re-
sults are represented as means 6
SEM. Significance was determined
by the Mann-Whitney U test. * P
,0.05, ** P ,0.02.1793 Cutler et al.
from both groups proliferated to an equal degree in re-
sponse to 1 mg of LPS (Fig. 6). Cross-linking of surface im-
munoglobulin molecules by an anti-Ig k chain mAb in the
presence of IL-4 also induced comparable proliferative re-
sponses in wild-type and C1qA2/2 mice. Furthermore,
stimulation of B cells through CD40, mimicking T–B cell
interaction, induced equivalent proliferative B cell re-
sponses in both experimental groups (Fig. 6).
Localization of Immune Complexes. The role of the clas-
sical pathway of complement in the localization of model
immune complexes was investigated using FITC-HAGG.
FITC-HAGG was located within the splenic follicles of
wild type mice 24 h after injection (Fig. 7 A), whereas no
equivalent follicular trapping was observed in C1qA2/2
mice (Fig. 7 B). Trapped FITC-HAGG was focused at the
apex of germinal centers within the follicle, revealed by
PNA staining (red; Fig. 7 A) and colocalized with FDCs
(yellow; Fig. 7 C) in wild-type mice, but not C1q-deficient
mice (Fig. 7 D). There was, however, clear uptake of
FITC-HAGG in the red pulp of C1qA2/2 mice (Fig. 7, B
and D) as there was in wild-type mice.
Discussion
Activation of the classical pathway of complement is well
known to be critical for the induction of IgG antibody re-
sponses after immunization with suboptimal doses of TD
antigen. Initial experiments using SRBCs confirmed this
immunological phenotype in C1qA2/2 mice. However, it
was apparent that the complement-deficient mice had the
capacity to produce antigen-specific class-switched IgG an-
tibody. Isotype-specific analysis of the primary antibody re-
sponse revealed a novel pattern of IgG isotype production
to both particulate and soluble protein TD antigen. Anti-
gen-specific IgG2a and IgG3 production was significantly
reduced in gene-targeted mice, whereas production of
other isotypes was similar to that of controls. The pheno-
type was consistent between C1qA2/2 mice from a mixed
(129/Sv 3 C57/BL6) or a pure (129/Sv) genetic back-
ground.
No primary defect was detected in the B cell compart-
ment, as B cells from C1qA2/2 mice proliferated normally
to TD stimuli in vitro. The selective reduction in IgG2a
and IgG3 production therefore suggested that cytokine
production by antigen-specific T cells may be abnormal in
C1qA2/2 mice. Ig class switching is thought to be induced
after contact with antigen-specific T cells (38). Further-
more, cytokine production by antigen-specific T cells is
known to influence antibody isotype production (39). IL-4
promotes the class switch to IgG1, whereas IFN-g stimu-
lates IgG2a isotype production (40) and possibly IgG3 pro-
duction (41). Although similar frequencies of antigen-spe-
cific T cells were primed in C1qA2/2 and wild-type mice,
T cells in C1qA2/2 mice produced diminished levels of
IFN-g, whereas secretion of IL-4 was equivalent in control
and gene-targeted mice. Reduced IFN-g production and
normal IL-4 production could explain the differences in
antibody isotype profiles observed.
Recent data suggest that cytokine production by anti-
gen-specific T cells may be influenced by interaction with
different APC populations. Activated B cells promote IL-4
secretion from antigen-specific T cells (42, 43), but cannot
produce IL-12 in a similar context (44). In contrast, T cell–
Figure 4. Analysis of T cell
priming. Wild-type (129/Sv; j;
n  5 4) and strain-matched
C1qA2/2 (s; n 5 4) were im-
munized intraperitoneally with
10  mg DNP-KLH precipitated in
alum. Precursor frequencies of
KLH-specific splenic T cells
were determined by IL-2 limit-
ing dilution analysis as detailed in
the experimental procedures sec-
tion.
Figure 5. Cytokine production by antigen-specific T cells. 129/Sv
(filled bars; n 5 5) and strain-matched C1qA2/2 (129/Sv; open bars; n 5 5)
mice were immunized intraperitoneally with 10 mg DNP-KLH in alum.
T cell cytokine production was assessed day 14 after priming. Whole
splenic cell suspensions were pulsed with KLH (10 mg/ml) and superna-
tants were harvested on days 4 and 7. (A) IFN-g production was mea-
sured by ELISA and (B) IL-4 production was measured by bioassay as de-
tailed in Materials and Methods. All results are represented as means 6 SD.
Significance was determined by the Mann-Whitney U test. (** P ,0.01).
Figure 6. B cell proliferation.
Purified B cell suspensions (2 3
105/ml) from wild-type (129/Sv
3 C57BL/6; filled bars; n 5 2) or
strain-matched  C1qA2/2 ( open
bars; n 5 2) mice were plated in
triplicate. B cells were then stim-
ulated with LPS (1 mg/ml), anti-
Ig k chain (10 mg/ml) plus IL-4,
or anti-CD40 treatment. B cell
proliferation was assessed at 48 h
by the uptake of [3H]thymidine.1794 Defective Immune Responses in C1q Knockout Mice
interdigitating dendritic cell (IDC) interaction promotes
IL-12 production by IDCs and subsequent IFN-g produc-
tion by antigen-specific T cells (45), as does T cell–mono-
cyte interaction (46). Notably, only IDCs pulsed with anti-
gen in vitro can induce production of antigen-specific
IgG2a in vivo (47, 48). In addition, IDCs in the presence
of activated T cells have been shown directly to induce ac-
tivated B cells to secrete IgG in vitro (49). It is of interest
that dendritic cells identified within murine germinal cen-
ters (GCDCs) express CD21 (50). However, it is not known
whether these GCDCs exhibit similar functions or secrete a
similar cytokine profile as IDCs. Antigen-specific CD41 T
(51) and B cells with class-switched Ig CH chains (52) ac-
cumulate within the germinal center during the follicular
phase of the antibody response. Interaction between anti-
gen-specific T cells, B cells, and GCDCs could be defective
in C1qA2/2 mice.
A direct interaction between C1q and APCs may be de-
ficient in C1qA2/2 mice. A number of cell types have been
shown to bind C1q (53). Furthermore, several receptors for
C1q have been proposed (54). Previous reports have sug-
gested that aggregated C1q can enhance Ig production in B
cells via interaction with C1q receptors (55). Notably,
macrophages also express a receptor for C1q, which has
been proposed to be involved in the enhancement of
phagocytosis of antigen (56, 57). It has also been tentatively
suggested that C1q synthesized by macrophages may play a
role in antibody production at sites of inflammation (53).
However, the function of C1q receptors in the immune re-
sponse remains controversial and will require further study.
Fischer et al. have recently studied the immune response
to TD antigen in C4 “knockout” mice. TD antigen-specific
total IgG and IgM production was reduced in C42/2mice.
However, antigen-specific isotype production was not
evaluated in this model of classical complement pathway
deficiency (8). In agreement with results in our study, T
cell priming was unaffected in C42/2 mice (8) and in mice
with complement receptors 1 and 2 blocked by specific
Figure 7. Absence of follicular localization of immune complexes in C1qA2/2 mice. Spleens from wild-type (129/Sv 3 C57BL/6; n 5 5) and strain-
matched C1qA2/2 (n 5 5) mice were taken 24 h after intravenous injection with 500 mg FITC-labeled HAGG. FITC localization (green) was assessed in
splenic sections relative to germinal centers (PNA expression; red) in wild-type (A) and C1qA2/2 (B) mice. FDCs were detected by mAb FDC-M1 (red)
in wild-type (C) and C1qA2/2 (D) mice. Original magnification: 20 (A, B, and D) and 40 (C).1795 Cutler et al.
mAbs (23). However, cytokine production by antigen-spe-
cific T cells has not been reported previously in comple-
ment-deficient mice. This study constitutes the first dem-
onstration that classical complement pathway activation is
essential for normal IFN-g production by antigen-specific
T cells and subsequent IgG2a and IgG3 production.
Localization of immune complexes to splenic lymphoid
follicles requires activation of the classical complement
pathway. Localized FITC-HAGG was concentrated on
FDC adjacent to germinal center B cells in wild-type mice.
FDCs express both Fc and complement receptors (58, 59).
Fc-g chain–deficient mice exhibited enhanced trapping of
immune complexes on FDCs (60). Clearly, activation of
the classical complement pathway and complement recep-
tors are essential for trapping immune complexes on FDCs.
Nevertheless, FITC label was detected in the splenic red
pulp of C1qA2/2 mice. A previous report showed that
HAGG injected intravenously was located in the red pulp
of the spleen and the marginal zone within 30 min of injec-
tion. At 8 h, HAGG localized to the splenic follicle (61).
Marginal zone B cells are proposed to transport immune
complexes to germinal centers via complement receptors
(62). It follows that in C1qA2/2 mice, FITC-HAGG cap-
tured by Fc receptors would not be transported to germinal
centers and may be catabolized by red pulp macrophages.
The poor secondary humoral response observed in
C1qA2/2 mice may be due to deficient trapping of anti-
gen–antibody complexes within the FDC network. FDCs
retain immune complexes in their native form on dendrites
for months after priming with antigen (63). Antigen is re-
leased as immune complex-coated bodies after challenge
with recall antigen (64) allowing uptake by memory B cells
(65). The retention and release of antigen by FDCs has
been implicated in the maintenance of antibody levels (63)
and in B cell memory (66). The defect in secondary anti-
body responses in C1qA2/2 mice might lie in defective
maintenance, but might also indicate failed selection of an-
tigen-specific B cells within the germinal center. Antigen
receptor engagement on B cells is known to be an impor-
tant signal for rescuing B cells from apoptosis (67). This sig-
nal can be provided by antigen on retained FDCs (15). The
failure in selection of antigen-specific B cells might not al-
low the formation of a B cell memory pool.
Recent studies using mice with targeted deletions of C3
and C4 (8) or Cr22/2 (26–28) emphasized the importance
of complement receptors on B cells in humoral responses
to TD antigens. Data from this study do not exclude the
possibility that enhancement of signaling through comple-
ment receptors on B cells is important in the induction of
normal humoral responses. However, complement-depen-
dent signals to specialized APC populations appear to be of
equal importance in the generation of normal antibody re-
sponses to TD antigens. Complement-dependent delivery
of antigen to FDCs may also be critical in the generation of
normal secondary antibody responses.
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